Conformational changes upon conversion of fibrinogen into fibrin: The mechanisms of exposure of cryptic sites

Annals of the New York Academy of Sciences

Volumn 936, Issue , 2001, Pages 185-204

  Medved, Leonid ^a   Tsurupa, Galina ^a   Yakovlev, Sergei ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Conversion; Cryptic sites; Fibrin; Fibrinogen; Plasminogen; tPA

Indexed keywords

EPITOPE; FIBRIN; FIBRINOGEN; MONOCLONAL ANTIBODY; PLASMINOGEN; POLYMER; TISSUE PLASMINOGEN ACTIVATOR;

BINDING SITE; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; FIBRIN POLYMERIZATION; FIBRINOLYSIS; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STABILITY;

EID: 0034969112     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03505.x     Document Type: Conference Paper

References (50)

1. Fibrinogen and fibrin
2. Fibrinogen structure and fibrin clot assembly
3. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation
4. Structural and functional characterization of proteolytic fragments derived from the C-terminal regions of bovine fibrinogen
5. Conversion of fibrinogen to fibrin: Mechanism of exposure of tPA- and plasminogen-binding sites
6. The sequence Aα-(148-160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies
7. The sequence γ-(312-324) is a fibrin-specific epitope
8. Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) αC-domains
9. Differential binding of histidine-rich glycoprotein (HRG) to human IgG subclasses and IgG molecules containing kappa and lambda light chains
10. Scanning microcalorimetry in studying temperature-induced changes in proteins
11. Thermodynamic analysis of scanning microcalorimetry data. 1. Algorithms for deconvolution of heat absorption curves
12. Domains in the fibrinogen molecule
13. A model for fibrinogen: Domains and sequence
14. Structural organization of C-terminal parts of fibrinogen Aα-chains
15. Electron microscopy of fibrinogen, its plasmic fragments and small polymers
16. The role of fibrinogen αC-domains in the fibrin assembly process
17. Fibrinogen αC-domains as the structure accelerating the fibrin assembly process
18. Carboxyl-terminal portions of the α chains of fibrinogen and fibrin. Localization by electron microscopy and the effect of isolated αC fragments on polymerization
19. Role of the αC domains of fibrin in clot formation
20. Amino acid sequence studies on the α chain of human fibrinogen. Exact location of cross-linking acceptor sites
21. Localization of the α-chain cross-link acceptor sites of human fibrin
22. Fibrinogen, fibrin and factor XIII
23. New perspectives in cell adhesion: RGD and integrins
24. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells
25. Fibrin - Recombinant human factor XIII a-subunit association
26. Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution
27. Cryoprecipitation of fibrin-fibrinogen complexes induced by the cold-insoluble globulin of plasma
28. A unique proteolytic fragment of human fibrinogen containing the Aα COOH-terminal domain of the native molecule
29. The interaction of human platelet thrombospondin with fibrinogen. Thrombospondin purification and specificity of interaction
30. Bovine plasma cold-insoluble globulin: Gross structure and function
31. Incorporation of thrombospondin into fibrin clots
32. 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor
33. 2-antiplasmin to fibrin(ogen)
34. Possible cross-linking of factor VIII related antigen to fibrin by factor XIII in delayed coagulation process
35. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation
36. Molecular basis for fibrinogen Dusard (Aα 554 Arg→Cys) and its association with abnormal fibrin polymerization and thrombophilia
37. Comparative structural and functional features of the human fibrinogen αC domain and the isolated αC fragment. Characterization using monoclonal antibodies to define COOH-terminal Aα chain regions
38. Factor XIIIa-catalyzed cross-linking of recombinant αC fragments of human fibrinogen
39. Sites in fibrin involved in the acceleration of plasminogen activation by t-PA. Possible role of fibrin polymerisation
40. Primary soluble plasmic degradation product of human cross-linked fibrin. Isolation and stoichiometry of the (DD)E complex
41. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin
42. Fibrinogen and fibrin: Biochemistry and pathophysiology
43. Domain organization of the terminal parts in the fibrinogen molecule
44. H fragment (95 kDa) leads to a significant increase in its anticlotting activity
45. Conformation of fibrinogen: Calorimetric evidence for a three-nodular structure
46. Domain structure and functional activity of the recombinant human fibrinogen γ-module (7148-411)
47. Crystal structure of fragment double-D from human fibrin with two different bound ligands
48. Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides
49. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots
50. Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide